These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. In Vitro Activities of Primaquine-Schizonticide Combinations on Asexual Blood Stages and Gametocytes of Plasmodium falciparum. Cabrera M; Cui L Antimicrob Agents Chemother; 2015 Dec; 59(12):7650-6. PubMed ID: 26416869 [TBL] [Abstract][Full Text] [Related]
5. In vitro genotoxicity of the West African anti-malarial herbal Cryptolepis sanguinolenta and its major alkaloid cryptolepine. Ansah C; Khan A; Gooderham NJ Toxicology; 2005 Mar; 208(1):141-7. PubMed ID: 15664441 [TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo antiplasmodial activity of cryptolepine and related alkaloids from Cryptolepis sanguinolenta. Cimanga K; De Bruyne T; Pieters L; Vlietinck AJ; Turger CA J Nat Prod; 1997 Jul; 60(7):688-91. PubMed ID: 9249972 [TBL] [Abstract][Full Text] [Related]
7. Comparative in vitro and in vivo antimalarial activity of the indole alkaloids ellipticine, olivacine, cryptolepine and a synthetic cryptolepine analog. Rocha e Silva LF; Montoia A; Amorim RC; Melo MR; Henrique MC; Nunomura SM; Costa MR; Andrade Neto VF; Costa DS; Dantas G; Lavrado J; Moreira R; Paulo A; Pinto AC; Tadei WP; Zacardi RS; Eberlin MN; Pohlit AM Phytomedicine; 2012 Dec; 20(1):71-6. PubMed ID: 23092722 [TBL] [Abstract][Full Text] [Related]
8. A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs. Quashie NB; Duah NO; Abuaku B; Quaye L; Ayanful-Torgby R; Akwoviah GA; Kweku M; Johnson JD; Lucchi NW; Udhayakumar V; Duplessis C; Kronmann KC; Koram KA Malar J; 2013 Dec; 12():450. PubMed ID: 24341604 [TBL] [Abstract][Full Text] [Related]
9. Effects of the anti-malarial compound cryptolepine and its analogues in human lymphocytes and sperm in the Comet assay. Gopalan RC; Emerce E; Wright CW; Karahalil B; Karakaya AE; Anderson D Toxicol Lett; 2011 Dec; 207(3):322-5. PubMed ID: 21946165 [TBL] [Abstract][Full Text] [Related]
10. Assessing the utility of an anti-malarial pharmacokinetic-pharmacodynamic model for aiding drug clinical development. Zaloumis S; Humberstone A; Charman SA; Price RN; Moehrle J; Gamo-Benito J; McCaw J; Jamsen KM; Smith K; Simpson JA Malar J; 2012 Aug; 11():303. PubMed ID: 22931058 [TBL] [Abstract][Full Text] [Related]
11. Activity of Herbal Medicines on Plasmodium falciparum Gametocytes: Implications for Malaria Transmission in Ghana. Amoah LE; Kakaney C; Kwansa-Bentum B; Kusi KA PLoS One; 2015; 10(11):e0142587. PubMed ID: 26562778 [TBL] [Abstract][Full Text] [Related]
12. Unravelling the pharmacological properties of cryptolepine and its derivatives: a mini-review insight. Tudu CK; Bandyopadhyay A; Kumar M; Radha ; Das T; Nandy S; Ghorai M; Gopalakrishnan AV; Proćków J; Dey A Naunyn Schmiedebergs Arch Pharmacol; 2023 Feb; 396(2):229-238. PubMed ID: 36251044 [TBL] [Abstract][Full Text] [Related]
13. Indoloquinoline Alkaloids as Antimalarials: Advances, Challenges, and Opportunities. Parvatkar PT; Diagne K; Zhao Y; Manetsch R ChemMedChem; 2024 Sep; 19(18):e202400254. PubMed ID: 38840271 [TBL] [Abstract][Full Text] [Related]
14. Recent Advances in the Chemistry and Pharmacology of Cryptolepine. Shnyder SD; Wright CW Prog Chem Org Nat Prod; 2021; 115():177-203. PubMed ID: 33797643 [TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum in vitro continuous culture conditions: A comparison of parasite susceptibility and tolerance to anti-malarial drugs throughout the asexual intra-erythrocytic life cycle. Duffy S; Avery VM Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):295-302. PubMed ID: 28738214 [TBL] [Abstract][Full Text] [Related]
16. Isoneocryptolepine, a synthetic indoloquinoline alkaloid, as an antiplasmodial lead compound. Van Miert S; Hostyn S; Maes BU; Cimanga K; Brun R; Kaiser M; Mátyus P; Dommisse R; Lemière G; Vlietinck A; Pieters L J Nat Prod; 2005 May; 68(5):674-7. PubMed ID: 15921407 [TBL] [Abstract][Full Text] [Related]
17. In vitro inhibition of beta-haematin formation, DNA interactions, antiplasmodial activity, and cytotoxicity of synthetic neocryptolepine derivatives. Van Miert S; Jonckers T; Cimanga K; Maes L; Maes B; Lemière G; Dommisse R; Vlietinck A; Pieters L Exp Parasitol; 2004; 108(3-4):163-8. PubMed ID: 15582513 [TBL] [Abstract][Full Text] [Related]
18. Isobolographic analysis of co-administration of two plant-derived antiplasmodial drug candidates, cryptolepine and xylopic acid, in Plasmodium berghei. Ameyaw EO; Asmah KB; Biney RP; Henneh IT; Owusu-Agyei P; Prah J; Forkuo AD Malar J; 2018 Apr; 17(1):153. PubMed ID: 29618354 [TBL] [Abstract][Full Text] [Related]
19. In vitro interaction of lumefantrine and piperaquine by atorvastatin against Plasmodium falciparum. Dormoi J; Savini H; Amalvict R; Baret E; Pradines B Malar J; 2014 May; 13():189. PubMed ID: 24886347 [TBL] [Abstract][Full Text] [Related]